nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFB11—uterine cancer	0.423	1	CbGaD
Metformin—NDUFS7—Doxorubicin—uterine cancer	0.0818	0.259	CbGbCtD
Metformin—NDUFS2—Doxorubicin—uterine cancer	0.0818	0.259	CbGbCtD
Metformin—NDUFS3—Doxorubicin—uterine cancer	0.0818	0.259	CbGbCtD
Metformin—SLC22A3—Progesterone—uterine cancer	0.0334	0.106	CbGbCtD
Metformin—SLC22A2—Progesterone—uterine cancer	0.0198	0.0626	CbGbCtD
Metformin—SLC22A1—Progesterone—uterine cancer	0.0172	0.0544	CbGbCtD
Metformin—NDUFA2—Podofilox—Etoposide—uterine cancer	0.00134	0.731	CbGdCrCtD
Metformin—NDUFAF4—Levonorgestrel—Progesterone—uterine cancer	0.000495	0.269	CbGdCrCtD
Metformin—NDUFA4L2—vagina—uterine cancer	0.000207	0.002	CbGeAlD
Metformin—NDUFA12—mammalian vulva—uterine cancer	0.000206	0.002	CbGeAlD
Metformin—NDUFB7—mammalian vulva—uterine cancer	0.000206	0.002	CbGeAlD
Metformin—NDUFS7—uterine cervix—uterine cancer	0.000206	0.00199	CbGeAlD
Metformin—NDUFS5—renal system—uterine cancer	0.000206	0.00199	CbGeAlD
Metformin—NDUFB8—renal system—uterine cancer	0.000206	0.00199	CbGeAlD
Metformin—NDUFB4—endometrium—uterine cancer	0.000205	0.00198	CbGeAlD
Metformin—NDUFS8—mammalian vulva—uterine cancer	0.000205	0.00198	CbGeAlD
Metformin—NDUFB1—mammalian vulva—uterine cancer	0.000205	0.00198	CbGeAlD
Metformin—NDUFAB1—endometrium—uterine cancer	0.000204	0.00197	CbGeAlD
Metformin—NDUFA2—female reproductive system—uterine cancer	0.000204	0.00197	CbGeAlD
Metformin—NDUFB9—endometrium—uterine cancer	0.000202	0.00196	CbGeAlD
Metformin—NDUFA8—endometrium—uterine cancer	0.000202	0.00196	CbGeAlD
Metformin—NDUFA11—uterus—uterine cancer	0.000202	0.00196	CbGeAlD
Metformin—NDUFB5—mammalian vulva—uterine cancer	0.000202	0.00195	CbGeAlD
Metformin—NDUFA6—mammalian vulva—uterine cancer	0.000202	0.00195	CbGeAlD
Metformin—NDUFA4—endometrium—uterine cancer	0.000201	0.00194	CbGeAlD
Metformin—NDUFAF4—uterus—uterine cancer	0.000201	0.00194	CbGeAlD
Metformin—NDUFB6—uterus—uterine cancer	0.000201	0.00194	CbGeAlD
Metformin—NDUFS4—mammalian vulva—uterine cancer	0.000201	0.00194	CbGeAlD
Metformin—NDUFB11—endometrium—uterine cancer	0.0002	0.00193	CbGeAlD
Metformin—NDUFV1—endometrium—uterine cancer	0.0002	0.00193	CbGeAlD
Metformin—NDUFS1—uterus—uterine cancer	0.000199	0.00193	CbGeAlD
Metformin—NDUFB8—endometrium—uterine cancer	0.000199	0.00192	CbGeAlD
Metformin—NDUFS5—endometrium—uterine cancer	0.000199	0.00192	CbGeAlD
Metformin—NDUFB4—mammalian vulva—uterine cancer	0.000198	0.00192	CbGeAlD
Metformin—NDUFAB1—mammalian vulva—uterine cancer	0.000197	0.0019	CbGeAlD
Metformin—NDUFB7—uterus—uterine cancer	0.000197	0.0019	CbGeAlD
Metformin—NDUFA8—mammalian vulva—uterine cancer	0.000196	0.00189	CbGeAlD
Metformin—NDUFB9—mammalian vulva—uterine cancer	0.000196	0.00189	CbGeAlD
Metformin—ND4L—female gonad—uterine cancer	0.000195	0.00189	CbGeAlD
Metformin—ND3—female gonad—uterine cancer	0.000195	0.00189	CbGeAlD
Metformin—ND2—female gonad—uterine cancer	0.000195	0.00189	CbGeAlD
Metformin—ND5—female gonad—uterine cancer	0.000195	0.00189	CbGeAlD
Metformin—NDUFS8—uterus—uterine cancer	0.000195	0.00189	CbGeAlD
Metformin—NDUFB1—uterus—uterine cancer	0.000195	0.00189	CbGeAlD
Metformin—NDUFA4—mammalian vulva—uterine cancer	0.000195	0.00188	CbGeAlD
Metformin—NDUFA10—female reproductive system—uterine cancer	0.000194	0.00188	CbGeAlD
Metformin—NDUFB11—mammalian vulva—uterine cancer	0.000193	0.00187	CbGeAlD
Metformin—NDUFV1—mammalian vulva—uterine cancer	0.000193	0.00187	CbGeAlD
Metformin—NDUFS7—renal system—uterine cancer	0.000193	0.00186	CbGeAlD
Metformin—NDUFB5—uterus—uterine cancer	0.000193	0.00186	CbGeAlD
Metformin—NDUFA6—uterus—uterine cancer	0.000193	0.00186	CbGeAlD
Metformin—NDUFB8—mammalian vulva—uterine cancer	0.000192	0.00186	CbGeAlD
Metformin—NDUFS5—mammalian vulva—uterine cancer	0.000192	0.00186	CbGeAlD
Metformin—NDUFS4—uterus—uterine cancer	0.000191	0.00185	CbGeAlD
Metformin—NDUFB2—female reproductive system—uterine cancer	0.000191	0.00185	CbGeAlD
Metformin—NDUFAF1—female reproductive system—uterine cancer	0.000189	0.00183	CbGeAlD
Metformin—ND4—female gonad—uterine cancer	0.000189	0.00183	CbGeAlD
Metformin—NDUFB4—uterus—uterine cancer	0.000189	0.00183	CbGeAlD
Metformin—PRKAB1—uterine cervix—uterine cancer	0.000188	0.00182	CbGeAlD
Metformin—ND6—female reproductive system—uterine cancer	0.000188	0.00182	CbGeAlD
Metformin—NDUFAB1—uterus—uterine cancer	0.000188	0.00181	CbGeAlD
Metformin—NDUFB3—female reproductive system—uterine cancer	0.000186	0.0018	CbGeAlD
Metformin—NDUFA4—uterus—uterine cancer	0.000185	0.00179	CbGeAlD
Metformin—NDUFA2—female gonad—uterine cancer	0.000185	0.00179	CbGeAlD
Metformin—NDUFB11—uterus—uterine cancer	0.000184	0.00178	CbGeAlD
Metformin—NDUFV1—uterus—uterine cancer	0.000184	0.00178	CbGeAlD
Metformin—NDUFA2—vagina—uterine cancer	0.000184	0.00178	CbGeAlD
Metformin—NDUFB8—uterus—uterine cancer	0.000183	0.00177	CbGeAlD
Metformin—NDUFS5—uterus—uterine cancer	0.000183	0.00177	CbGeAlD
Metformin—NDUFA11—female reproductive system—uterine cancer	0.000182	0.00176	CbGeAlD
Metformin—NDUFA5—female reproductive system—uterine cancer	0.000182	0.00176	CbGeAlD
Metformin—NDUFAF4—female reproductive system—uterine cancer	0.000181	0.00175	CbGeAlD
Metformin—NDUFB6—female reproductive system—uterine cancer	0.000181	0.00175	CbGeAlD
Metformin—PRKAB1—decidua—uterine cancer	0.000179	0.00174	CbGeAlD
Metformin—NDUFS1—female reproductive system—uterine cancer	0.000179	0.00173	CbGeAlD
Metformin—NDUFC2—epithelium—uterine cancer	0.000179	0.00173	CbGeAlD
Metformin—NDUFB10—female reproductive system—uterine cancer	0.000178	0.00172	CbGeAlD
Metformin—NDUFC2—uterine cervix—uterine cancer	0.000178	0.00172	CbGeAlD
Metformin—NDUFA10—female gonad—uterine cancer	0.000177	0.00171	CbGeAlD
Metformin—NDUFA12—female reproductive system—uterine cancer	0.000177	0.00171	CbGeAlD
Metformin—NDUFB7—female reproductive system—uterine cancer	0.000177	0.00171	CbGeAlD
Metformin—PRKAB1—renal system—uterine cancer	0.000176	0.0017	CbGeAlD
Metformin—NDUFS8—female reproductive system—uterine cancer	0.000176	0.0017	CbGeAlD
Metformin—NDUFC1—female gonad—uterine cancer	0.000175	0.00169	CbGeAlD
Metformin—NDUFC1—vagina—uterine cancer	0.000174	0.00168	CbGeAlD
Metformin—NDUFB2—female gonad—uterine cancer	0.000174	0.00168	CbGeAlD
Metformin—NDUFB5—female reproductive system—uterine cancer	0.000173	0.00167	CbGeAlD
Metformin—NDUFA6—female reproductive system—uterine cancer	0.000173	0.00167	CbGeAlD
Metformin—NDUFB2—vagina—uterine cancer	0.000173	0.00167	CbGeAlD
Metformin—NDUFAF1—female gonad—uterine cancer	0.000172	0.00167	CbGeAlD
Metformin—NDUFS4—female reproductive system—uterine cancer	0.000172	0.00166	CbGeAlD
Metformin—NDUFA7—lymph node—uterine cancer	0.000172	0.00166	CbGeAlD
Metformin—NDUFAF1—vagina—uterine cancer	0.000171	0.00166	CbGeAlD
Metformin—ND6—female gonad—uterine cancer	0.000171	0.00165	CbGeAlD
Metformin—NDUFS2—uterine cervix—uterine cancer	0.000171	0.00165	CbGeAlD
Metformin—PRKAB1—endometrium—uterine cancer	0.00017	0.00165	CbGeAlD
Metformin—NDUFB4—female reproductive system—uterine cancer	0.00017	0.00164	CbGeAlD
Metformin—NDUFB3—female gonad—uterine cancer	0.000169	0.00164	CbGeAlD
Metformin—NDUFAF2—female gonad—uterine cancer	0.000169	0.00164	CbGeAlD
Metformin—NDUFC2—decidua—uterine cancer	0.000169	0.00164	CbGeAlD
Metformin—NDUFAB1—female reproductive system—uterine cancer	0.000169	0.00163	CbGeAlD
Metformin—NDUFS3—uterine cervix—uterine cancer	0.000169	0.00163	CbGeAlD
Metformin—NDUFB3—vagina—uterine cancer	0.000168	0.00163	CbGeAlD
Metformin—NDUFAF2—vagina—uterine cancer	0.000168	0.00163	CbGeAlD
Metformin—NDUFB9—female reproductive system—uterine cancer	0.000168	0.00162	CbGeAlD
Metformin—NDUFA8—female reproductive system—uterine cancer	0.000168	0.00162	CbGeAlD
Metformin—NDUFA4—female reproductive system—uterine cancer	0.000167	0.00161	CbGeAlD
Metformin—NDUFC2—renal system—uterine cancer	0.000166	0.00161	CbGeAlD
Metformin—NDUFS2—smooth muscle tissue—uterine cancer	0.000166	0.0016	CbGeAlD
Metformin—NDUFB11—female reproductive system—uterine cancer	0.000166	0.0016	CbGeAlD
Metformin—NDUFV1—female reproductive system—uterine cancer	0.000166	0.0016	CbGeAlD
Metformin—NDUFA5—female gonad—uterine cancer	0.000166	0.0016	CbGeAlD
Metformin—NDUFA11—female gonad—uterine cancer	0.000166	0.0016	CbGeAlD
Metformin—PRKAB1—mammalian vulva—uterine cancer	0.000165	0.00159	CbGeAlD
Metformin—NDUFS5—female reproductive system—uterine cancer	0.000165	0.00159	CbGeAlD
Metformin—NDUFB8—female reproductive system—uterine cancer	0.000165	0.00159	CbGeAlD
Metformin—NDUFA5—vagina—uterine cancer	0.000165	0.00159	CbGeAlD
Metformin—NDUFA11—vagina—uterine cancer	0.000165	0.00159	CbGeAlD
Metformin—NDUFB6—female gonad—uterine cancer	0.000164	0.00159	CbGeAlD
Metformin—NDUFAF4—female gonad—uterine cancer	0.000164	0.00159	CbGeAlD
Metformin—NDUFS3—smooth muscle tissue—uterine cancer	0.000164	0.00158	CbGeAlD
Metformin—NDUFAF4—vagina—uterine cancer	0.000163	0.00158	CbGeAlD
Metformin—NDUFB6—vagina—uterine cancer	0.000163	0.00158	CbGeAlD
Metformin—NDUFS1—female gonad—uterine cancer	0.000163	0.00158	CbGeAlD
Metformin—NDUFS2—decidua—uterine cancer	0.000163	0.00157	CbGeAlD
Metformin—NDUFB10—female gonad—uterine cancer	0.000162	0.00157	CbGeAlD
Metformin—NDUFB10—vagina—uterine cancer	0.000161	0.00156	CbGeAlD
Metformin—NDUFA12—female gonad—uterine cancer	0.000161	0.00155	CbGeAlD
Metformin—NDUFB7—female gonad—uterine cancer	0.000161	0.00155	CbGeAlD
Metformin—NDUFS3—decidua—uterine cancer	0.000161	0.00155	CbGeAlD
Metformin—NDUFC2—endometrium—uterine cancer	0.000161	0.00155	CbGeAlD
Metformin—NDUFA12—vagina—uterine cancer	0.00016	0.00155	CbGeAlD
Metformin—NDUFB7—vagina—uterine cancer	0.00016	0.00155	CbGeAlD
Metformin—NDUFB1—female gonad—uterine cancer	0.00016	0.00154	CbGeAlD
Metformin—NDUFS8—female gonad—uterine cancer	0.00016	0.00154	CbGeAlD
Metformin—NDUFS2—renal system—uterine cancer	0.00016	0.00154	CbGeAlD
Metformin—NDUFB1—vagina—uterine cancer	0.000159	0.00153	CbGeAlD
Metformin—NDUFS8—vagina—uterine cancer	0.000159	0.00153	CbGeAlD
Metformin—NDUFS3—renal system—uterine cancer	0.000158	0.00152	CbGeAlD
Metformin—NDUFB5—female gonad—uterine cancer	0.000158	0.00152	CbGeAlD
Metformin—NDUFA6—female gonad—uterine cancer	0.000158	0.00152	CbGeAlD
Metformin—PRKAB1—uterus—uterine cancer	0.000157	0.00152	CbGeAlD
Metformin—NDUFB5—vagina—uterine cancer	0.000157	0.00151	CbGeAlD
Metformin—NDUFA6—vagina—uterine cancer	0.000157	0.00151	CbGeAlD
Metformin—NDUFS4—female gonad—uterine cancer	0.000157	0.00151	CbGeAlD
Metformin—NDUFS4—vagina—uterine cancer	0.000156	0.0015	CbGeAlD
Metformin—NDUFC2—mammalian vulva—uterine cancer	0.000155	0.0015	CbGeAlD
Metformin—NDUFB4—female gonad—uterine cancer	0.000155	0.00149	CbGeAlD
Metformin—NDUFS2—endometrium—uterine cancer	0.000154	0.00149	CbGeAlD
Metformin—NDUFS7—female reproductive system—uterine cancer	0.000154	0.00149	CbGeAlD
Metformin—NDUFB4—vagina—uterine cancer	0.000154	0.00148	CbGeAlD
Metformin—NDUFAB1—female gonad—uterine cancer	0.000154	0.00148	CbGeAlD
Metformin—NDUFAB1—vagina—uterine cancer	0.000153	0.00148	CbGeAlD
Metformin—NDUFB9—female gonad—uterine cancer	0.000153	0.00148	CbGeAlD
Metformin—NDUFA8—female gonad—uterine cancer	0.000153	0.00148	CbGeAlD
Metformin—NDUFS3—endometrium—uterine cancer	0.000152	0.00147	CbGeAlD
Metformin—NDUFB9—vagina—uterine cancer	0.000152	0.00147	CbGeAlD
Metformin—NDUFA8—vagina—uterine cancer	0.000152	0.00147	CbGeAlD
Metformin—NDUFA4—female gonad—uterine cancer	0.000152	0.00147	CbGeAlD
Metformin—NDUFV1—female gonad—uterine cancer	0.000151	0.00146	CbGeAlD
Metformin—NDUFB11—female gonad—uterine cancer	0.000151	0.00146	CbGeAlD
Metformin—NDUFA4—vagina—uterine cancer	0.000151	0.00146	CbGeAlD
Metformin—NDUFS5—female gonad—uterine cancer	0.00015	0.00145	CbGeAlD
Metformin—NDUFB8—female gonad—uterine cancer	0.00015	0.00145	CbGeAlD
Metformin—NDUFV1—vagina—uterine cancer	0.00015	0.00145	CbGeAlD
Metformin—NDUFB11—vagina—uterine cancer	0.00015	0.00145	CbGeAlD
Metformin—NDUFS2—mammalian vulva—uterine cancer	0.000149	0.00144	CbGeAlD
Metformin—NDUFB8—vagina—uterine cancer	0.000149	0.00144	CbGeAlD
Metformin—NDUFS5—vagina—uterine cancer	0.000149	0.00144	CbGeAlD
Metformin—NDUFC2—uterus—uterine cancer	0.000148	0.00143	CbGeAlD
Metformin—NDUFS3—mammalian vulva—uterine cancer	0.000148	0.00143	CbGeAlD
Metformin—NDUFS2—uterus—uterine cancer	0.000142	0.00138	CbGeAlD
Metformin—PRKAB1—female reproductive system—uterine cancer	0.000141	0.00136	CbGeAlD
Metformin—NDUFS3—uterus—uterine cancer	0.000141	0.00136	CbGeAlD
Metformin—NDUFS7—female gonad—uterine cancer	0.00014	0.00136	CbGeAlD
Metformin—NDUFS7—vagina—uterine cancer	0.00014	0.00135	CbGeAlD
Metformin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.00229	CcSEcCtD
Metformin—Malaise—Dactinomycin—uterine cancer	0.000139	0.00229	CcSEcCtD
Metformin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000138	0.00228	CcSEcCtD
Metformin—NDUFV2—lymph node—uterine cancer	0.000137	0.00133	CbGeAlD
Metformin—ND1—smooth muscle tissue—uterine cancer	0.000136	0.00132	CbGeAlD
Metformin—Hepatobiliary disease—Etoposide—uterine cancer	0.000135	0.00223	CcSEcCtD
Metformin—Neuropathy—Epirubicin—uterine cancer	0.000134	0.00222	CcSEcCtD
Metformin—NDUFA4L2—lymph node—uterine cancer	0.000134	0.00129	CbGeAlD
Metformin—NDUFC2—female reproductive system—uterine cancer	0.000133	0.00129	CbGeAlD
Metformin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000133	0.00219	CcSEcCtD
Metformin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000132	0.00218	CcSEcCtD
Metformin—Myalgia—Dactinomycin—uterine cancer	0.000131	0.00216	CcSEcCtD
Metformin—ND1—renal system—uterine cancer	0.000131	0.00127	CbGeAlD
Metformin—Discomfort—Dactinomycin—uterine cancer	0.00013	0.00214	CcSEcCtD
Metformin—PRKAB1—female gonad—uterine cancer	0.000128	0.00124	CbGeAlD
Metformin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000128	0.00211	CcSEcCtD
Metformin—NDUFS2—female reproductive system—uterine cancer	0.000128	0.00124	CbGeAlD
Metformin—Asthenia—Progesterone—uterine cancer	0.000128	0.00211	CcSEcCtD
Metformin—PRKAB1—vagina—uterine cancer	0.000128	0.00123	CbGeAlD
Metformin—Hypoaesthesia—Etoposide—uterine cancer	0.000128	0.0021	CcSEcCtD
Metformin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000128	0.0021	CcSEcCtD
Metformin—NDUFS3—female reproductive system—uterine cancer	0.000126	0.00122	CbGeAlD
Metformin—Pruritus—Progesterone—uterine cancer	0.000126	0.00208	CcSEcCtD
Metformin—Oedema—Dactinomycin—uterine cancer	0.000126	0.00208	CcSEcCtD
Metformin—ND2—lymph node—uterine cancer	0.000126	0.00121	CbGeAlD
Metformin—ND3—lymph node—uterine cancer	0.000126	0.00121	CbGeAlD
Metformin—ND4L—lymph node—uterine cancer	0.000126	0.00121	CbGeAlD
Metformin—ND5—lymph node—uterine cancer	0.000126	0.00121	CbGeAlD
Metformin—Infection—Dactinomycin—uterine cancer	0.000125	0.00206	CcSEcCtD
Metformin—Neuropathy—Doxorubicin—uterine cancer	0.000124	0.00205	CcSEcCtD
Metformin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000123	0.00203	CcSEcCtD
Metformin—SLC47A1—myometrium—uterine cancer	0.000122	0.00118	CbGeAlD
Metformin—Diarrhoea—Progesterone—uterine cancer	0.000122	0.00201	CcSEcCtD
Metformin—ND4—lymph node—uterine cancer	0.000122	0.00118	CbGeAlD
Metformin—NDUFC2—female gonad—uterine cancer	0.000121	0.00117	CbGeAlD
Metformin—NDUFC2—vagina—uterine cancer	0.00012	0.00116	CbGeAlD
Metformin—Anorexia—Dactinomycin—uterine cancer	0.00012	0.00198	CcSEcCtD
Metformin—Eye disorder—Etoposide—uterine cancer	0.00012	0.00198	CcSEcCtD
Metformin—NDUFA2—lymph node—uterine cancer	0.000119	0.00115	CbGeAlD
Metformin—Cardiac disorder—Etoposide—uterine cancer	0.000119	0.00196	CcSEcCtD
Metformin—Flushing—Etoposide—uterine cancer	0.000119	0.00196	CcSEcCtD
Metformin—Dizziness—Progesterone—uterine cancer	0.000118	0.00194	CcSEcCtD
Metformin—NDUFS2—female gonad—uterine cancer	0.000116	0.00112	CbGeAlD
Metformin—Angiopathy—Etoposide—uterine cancer	0.000116	0.00192	CcSEcCtD
Metformin—Immune system disorder—Etoposide—uterine cancer	0.000116	0.00191	CcSEcCtD
Metformin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000116	0.00191	CcSEcCtD
Metformin—NDUFS2—vagina—uterine cancer	0.000116	0.00112	CbGeAlD
Metformin—Mediastinal disorder—Etoposide—uterine cancer	0.000116	0.00191	CcSEcCtD
Metformin—Chills—Etoposide—uterine cancer	0.000115	0.0019	CcSEcCtD
Metformin—NDUFS3—female gonad—uterine cancer	0.000115	0.00111	CbGeAlD
Metformin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000115	0.00189	CcSEcCtD
Metformin—NDUFS3—vagina—uterine cancer	0.000114	0.0011	CbGeAlD
Metformin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000114	0.00188	CcSEcCtD
Metformin—NDUFA10—lymph node—uterine cancer	0.000114	0.0011	CbGeAlD
Metformin—Vomiting—Progesterone—uterine cancer	0.000113	0.00187	CcSEcCtD
Metformin—NDUFC1—lymph node—uterine cancer	0.000113	0.00109	CbGeAlD
Metformin—Rash—Progesterone—uterine cancer	0.000112	0.00185	CcSEcCtD
Metformin—Dermatitis—Progesterone—uterine cancer	0.000112	0.00185	CcSEcCtD
Metformin—NDUFB2—lymph node—uterine cancer	0.000112	0.00108	CbGeAlD
Metformin—Headache—Progesterone—uterine cancer	0.000112	0.00184	CcSEcCtD
Metformin—NDUFAF1—lymph node—uterine cancer	0.000111	0.00107	CbGeAlD
Metformin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00011	0.00182	CcSEcCtD
Metformin—ND6—lymph node—uterine cancer	0.00011	0.00106	CbGeAlD
Metformin—Decreased appetite—Dactinomycin—uterine cancer	0.000109	0.0018	CcSEcCtD
Metformin—Dysgeusia—Etoposide—uterine cancer	0.000109	0.0018	CcSEcCtD
Metformin—Renal impairment—Epirubicin—uterine cancer	0.000109	0.0018	CcSEcCtD
Metformin—NDUFAF2—lymph node—uterine cancer	0.000109	0.00105	CbGeAlD
Metformin—NDUFB3—lymph node—uterine cancer	0.000109	0.00105	CbGeAlD
Metformin—Fatigue—Dactinomycin—uterine cancer	0.000108	0.00179	CcSEcCtD
Metformin—Muscle spasms—Etoposide—uterine cancer	0.000107	0.00177	CcSEcCtD
Metformin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000107	0.00176	CcSEcCtD
Metformin—NDUFA5—lymph node—uterine cancer	0.000106	0.00103	CbGeAlD
Metformin—NDUFA11—lymph node—uterine cancer	0.000106	0.00103	CbGeAlD
Metformin—Hypoglycaemia—Epirubicin—uterine cancer	0.000106	0.00176	CcSEcCtD
Metformin—Lethargy—Epirubicin—uterine cancer	0.000106	0.00175	CcSEcCtD
Metformin—Nausea—Progesterone—uterine cancer	0.000106	0.00174	CcSEcCtD
Metformin—NDUFAF4—lymph node—uterine cancer	0.000106	0.00102	CbGeAlD
Metformin—NDUFB6—lymph node—uterine cancer	0.000106	0.00102	CbGeAlD
Metformin—SLC22A2—renal system—uterine cancer	0.000105	0.00102	CbGeAlD
Metformin—ND1—female reproductive system—uterine cancer	0.000105	0.00101	CbGeAlD
Metformin—NDUFS1—lymph node—uterine cancer	0.000105	0.00101	CbGeAlD
Metformin—NDUFB10—lymph node—uterine cancer	0.000104	0.00101	CbGeAlD
Metformin—Pain in extremity—Epirubicin—uterine cancer	0.000104	0.00171	CcSEcCtD
Metformin—Feeling abnormal—Dactinomycin—uterine cancer	0.000104	0.00171	CcSEcCtD
Metformin—Ill-defined disorder—Etoposide—uterine cancer	0.000104	0.00171	CcSEcCtD
Metformin—NDUFB7—lymph node—uterine cancer	0.000103	0.000999	CbGeAlD
Metformin—NDUFA12—lymph node—uterine cancer	0.000103	0.000999	CbGeAlD
Metformin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000103	0.0017	CcSEcCtD
Metformin—NDUFB1—lymph node—uterine cancer	0.000103	0.000993	CbGeAlD
Metformin—NDUFS8—lymph node—uterine cancer	0.000103	0.000993	CbGeAlD
Metformin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000103	0.00169	CcSEcCtD
Metformin—Migraine—Epirubicin—uterine cancer	0.000102	0.00169	CcSEcCtD
Metformin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000102	0.00168	CcSEcCtD
Metformin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000102	0.00168	CcSEcCtD
Metformin—NDUFB5—lymph node—uterine cancer	0.000101	0.000979	CbGeAlD
Metformin—NDUFA6—lymph node—uterine cancer	0.000101	0.000979	CbGeAlD
Metformin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000101	0.00167	CcSEcCtD
Metformin—Renal impairment—Doxorubicin—uterine cancer	0.000101	0.00167	CcSEcCtD
Metformin—NDUFS4—lymph node—uterine cancer	0.000101	0.000973	CbGeAlD
Metformin—Malaise—Etoposide—uterine cancer	0.000101	0.00166	CcSEcCtD
Metformin—Abdominal pain—Dactinomycin—uterine cancer	9.95e-05	0.00164	CcSEcCtD
Metformin—NDUFB4—lymph node—uterine cancer	9.93e-05	0.00096	CbGeAlD
Metformin—NDUFAB1—lymph node—uterine cancer	9.87e-05	0.000954	CbGeAlD
Metformin—Hypoglycaemia—Doxorubicin—uterine cancer	9.85e-05	0.00162	CcSEcCtD
Metformin—NDUFB9—lymph node—uterine cancer	9.81e-05	0.000948	CbGeAlD
Metformin—NDUFA8—lymph node—uterine cancer	9.81e-05	0.000948	CbGeAlD
Metformin—Loss of consciousness—Etoposide—uterine cancer	9.81e-05	0.00162	CcSEcCtD
Metformin—Lethargy—Doxorubicin—uterine cancer	9.81e-05	0.00162	CcSEcCtD
Metformin—NDUFA4—lymph node—uterine cancer	9.75e-05	0.000943	CbGeAlD
Metformin—SLC22A3—myometrium—uterine cancer	9.75e-05	0.000942	CbGeAlD
Metformin—NDUFB11—lymph node—uterine cancer	9.69e-05	0.000937	CbGeAlD
Metformin—NDUFV1—lymph node—uterine cancer	9.69e-05	0.000937	CbGeAlD
Metformin—Dehydration—Epirubicin—uterine cancer	9.66e-05	0.00159	CcSEcCtD
Metformin—NDUFB8—lymph node—uterine cancer	9.63e-05	0.000931	CbGeAlD
Metformin—NDUFS5—lymph node—uterine cancer	9.63e-05	0.000931	CbGeAlD
Metformin—Hypertension—Etoposide—uterine cancer	9.63e-05	0.00159	CcSEcCtD
Metformin—Pain in extremity—Doxorubicin—uterine cancer	9.61e-05	0.00158	CcSEcCtD
Metformin—Liver function test abnormal—Epirubicin—uterine cancer	9.59e-05	0.00158	CcSEcCtD
Metformin—Nausea—Medroxyprogesterone Acetate—uterine cancer	9.58e-05	0.00158	CcSEcCtD
Metformin—ND1—female gonad—uterine cancer	9.55e-05	0.000923	CbGeAlD
Metformin—SLC47A1—uterine cervix—uterine cancer	9.51e-05	0.00092	CbGeAlD
Metformin—Chest pain—Etoposide—uterine cancer	9.5e-05	0.00157	CcSEcCtD
Metformin—Abdominal pain upper—Epirubicin—uterine cancer	9.48e-05	0.00156	CcSEcCtD
Metformin—Migraine—Doxorubicin—uterine cancer	9.46e-05	0.00156	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	9.43e-05	0.00156	CcSEcCtD
Metformin—Discomfort—Etoposide—uterine cancer	9.38e-05	0.00155	CcSEcCtD
Metformin—Breast disorder—Epirubicin—uterine cancer	9.38e-05	0.00155	CcSEcCtD
Metformin—Nasopharyngitis—Epirubicin—uterine cancer	9.29e-05	0.00153	CcSEcCtD
Metformin—SLC47A1—decidua—uterine cancer	9.06e-05	0.000876	CbGeAlD
Metformin—Infection—Etoposide—uterine cancer	9.05e-05	0.00149	CcSEcCtD
Metformin—Abdominal distension—Epirubicin—uterine cancer	9.04e-05	0.00149	CcSEcCtD
Metformin—NDUFS7—lymph node—uterine cancer	9.03e-05	0.000873	CbGeAlD
Metformin—Asthenia—Dactinomycin—uterine cancer	9.03e-05	0.00149	CcSEcCtD
Metformin—Influenza—Epirubicin—uterine cancer	8.98e-05	0.00148	CcSEcCtD
Metformin—Dehydration—Doxorubicin—uterine cancer	8.94e-05	0.00147	CcSEcCtD
Metformin—Thrombocytopenia—Etoposide—uterine cancer	8.92e-05	0.00147	CcSEcCtD
Metformin—SLC47A1—renal system—uterine cancer	8.9e-05	0.00086	CbGeAlD
Metformin—Liver function test abnormal—Doxorubicin—uterine cancer	8.87e-05	0.00146	CcSEcCtD
Metformin—Skin disorder—Etoposide—uterine cancer	8.84e-05	0.00146	CcSEcCtD
Metformin—Hyperhidrosis—Etoposide—uterine cancer	8.8e-05	0.00145	CcSEcCtD
Metformin—Pancreatitis—Epirubicin—uterine cancer	8.8e-05	0.00145	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—uterine cancer	8.78e-05	0.00145	CcSEcCtD
Metformin—Angina pectoris—Epirubicin—uterine cancer	8.74e-05	0.00144	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—uterine cancer	8.68e-05	0.00143	CcSEcCtD
Metformin—Anorexia—Etoposide—uterine cancer	8.68e-05	0.00143	CcSEcCtD
Metformin—Diarrhoea—Dactinomycin—uterine cancer	8.61e-05	0.00142	CcSEcCtD
Metformin—SLC47A1—endometrium—uterine cancer	8.6e-05	0.000832	CbGeAlD
Metformin—Nasopharyngitis—Doxorubicin—uterine cancer	8.59e-05	0.00142	CcSEcCtD
Metformin—Hypotension—Etoposide—uterine cancer	8.51e-05	0.0014	CcSEcCtD
Metformin—Neutropenia—Epirubicin—uterine cancer	8.39e-05	0.00138	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—uterine cancer	8.36e-05	0.00138	CcSEcCtD
Metformin—Upper respiratory tract infection—Epirubicin—uterine cancer	8.34e-05	0.00138	CcSEcCtD
Metformin—SLC47A1—mammalian vulva—uterine cancer	8.32e-05	0.000804	CbGeAlD
Metformin—Influenza—Doxorubicin—uterine cancer	8.3e-05	0.00137	CcSEcCtD
Metformin—PRKAB1—lymph node—uterine cancer	8.26e-05	0.000798	CbGeAlD
Metformin—Paraesthesia—Etoposide—uterine cancer	8.18e-05	0.00135	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—uterine cancer	8.14e-05	0.00134	CcSEcCtD
Metformin—Dyspnoea—Etoposide—uterine cancer	8.12e-05	0.00134	CcSEcCtD
Metformin—Somnolence—Etoposide—uterine cancer	8.09e-05	0.00134	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—uterine cancer	8.09e-05	0.00133	CcSEcCtD
Metformin—Infestation NOS—Epirubicin—uterine cancer	8e-05	0.00132	CcSEcCtD
Metformin—Infestation—Epirubicin—uterine cancer	8e-05	0.00132	CcSEcCtD
Metformin—Drowsiness—Epirubicin—uterine cancer	8e-05	0.00132	CcSEcCtD
Metformin—Vomiting—Dactinomycin—uterine cancer	8e-05	0.00132	CcSEcCtD
Metformin—Rash—Dactinomycin—uterine cancer	7.93e-05	0.00131	CcSEcCtD
Metformin—SLC47A1—uterus—uterine cancer	7.93e-05	0.000766	CbGeAlD
Metformin—Decreased appetite—Etoposide—uterine cancer	7.92e-05	0.00131	CcSEcCtD
Metformin—Gastrointestinal disorder—Etoposide—uterine cancer	7.86e-05	0.0013	CcSEcCtD
Metformin—Fatigue—Etoposide—uterine cancer	7.85e-05	0.00129	CcSEcCtD
Metformin—Neuropathy peripheral—Epirubicin—uterine cancer	7.84e-05	0.00129	CcSEcCtD
Metformin—Constipation—Etoposide—uterine cancer	7.79e-05	0.00128	CcSEcCtD
Metformin—NDUFC2—lymph node—uterine cancer	7.78e-05	0.000752	CbGeAlD
Metformin—Neutropenia—Doxorubicin—uterine cancer	7.77e-05	0.00128	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—uterine cancer	7.72e-05	0.00127	CcSEcCtD
Metformin—SLC22A3—uterine cervix—uterine cancer	7.59e-05	0.000733	CbGeAlD
Metformin—Hepatobiliary disease—Epirubicin—uterine cancer	7.57e-05	0.00125	CcSEcCtD
Metformin—Feeling abnormal—Etoposide—uterine cancer	7.5e-05	0.00124	CcSEcCtD
Metformin—NDUFS2—lymph node—uterine cancer	7.48e-05	0.000723	CbGeAlD
Metformin—Nausea—Dactinomycin—uterine cancer	7.47e-05	0.00123	CcSEcCtD
Metformin—Gastrointestinal pain—Etoposide—uterine cancer	7.45e-05	0.00123	CcSEcCtD
Metformin—SLC22A1—renal system—uterine cancer	7.43e-05	0.000718	CbGeAlD
Metformin—Infestation NOS—Doxorubicin—uterine cancer	7.4e-05	0.00122	CcSEcCtD
Metformin—Infestation—Doxorubicin—uterine cancer	7.4e-05	0.00122	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—uterine cancer	7.4e-05	0.00122	CcSEcCtD
Metformin—NDUFS3—lymph node—uterine cancer	7.39e-05	0.000714	CbGeAlD
Metformin—SLC22A3—smooth muscle tissue—uterine cancer	7.37e-05	0.000713	CbGeAlD
Metformin—Bradycardia—Epirubicin—uterine cancer	7.31e-05	0.00121	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—uterine cancer	7.26e-05	0.0012	CcSEcCtD
Metformin—Urticaria—Etoposide—uterine cancer	7.23e-05	0.00119	CcSEcCtD
Metformin—Rhinitis—Epirubicin—uterine cancer	7.2e-05	0.00119	CcSEcCtD
Metformin—Abdominal pain—Etoposide—uterine cancer	7.2e-05	0.00119	CcSEcCtD
Metformin—Hepatitis—Epirubicin—uterine cancer	7.18e-05	0.00119	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—uterine cancer	7.15e-05	0.00118	CcSEcCtD
Metformin—SLC47A1—female reproductive system—uterine cancer	7.13e-05	0.000689	CbGeAlD
Metformin—SLC22A3—renal system—uterine cancer	7.1e-05	0.000686	CbGeAlD
Metformin—Oedema peripheral—Epirubicin—uterine cancer	7.08e-05	0.00117	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—uterine cancer	7.06e-05	0.00116	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—uterine cancer	7e-05	0.00116	CcSEcCtD
Metformin—SLC22A3—endometrium—uterine cancer	6.86e-05	0.000663	CbGeAlD
Metformin—Bradycardia—Doxorubicin—uterine cancer	6.77e-05	0.00112	CcSEcCtD
Metformin—Eye disorder—Epirubicin—uterine cancer	6.71e-05	0.00111	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—uterine cancer	6.67e-05	0.0011	CcSEcCtD
Metformin—Flushing—Epirubicin—uterine cancer	6.67e-05	0.0011	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—uterine cancer	6.66e-05	0.0011	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—uterine cancer	6.65e-05	0.0011	CcSEcCtD
Metformin—SLC22A3—mammalian vulva—uterine cancer	6.64e-05	0.000642	CbGeAlD
Metformin—Hypoaesthesia—Doxorubicin—uterine cancer	6.61e-05	0.00109	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—uterine cancer	6.55e-05	0.00108	CcSEcCtD
Metformin—Asthenia—Etoposide—uterine cancer	6.53e-05	0.00108	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—uterine cancer	6.53e-05	0.00108	CcSEcCtD
Metformin—Angiopathy—Epirubicin—uterine cancer	6.52e-05	0.00108	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—uterine cancer	6.49e-05	0.00107	CcSEcCtD
Metformin—SLC47A1—female gonad—uterine cancer	6.49e-05	0.000627	CbGeAlD
Metformin—Mediastinal disorder—Epirubicin—uterine cancer	6.47e-05	0.00107	CcSEcCtD
Metformin—Chills—Epirubicin—uterine cancer	6.45e-05	0.00106	CcSEcCtD
Metformin—SLC47A1—vagina—uterine cancer	6.45e-05	0.000623	CbGeAlD
Metformin—Pruritus—Etoposide—uterine cancer	6.44e-05	0.00106	CcSEcCtD
Metformin—Erythema—Epirubicin—uterine cancer	6.25e-05	0.00103	CcSEcCtD
Metformin—Malnutrition—Epirubicin—uterine cancer	6.25e-05	0.00103	CcSEcCtD
Metformin—Diarrhoea—Etoposide—uterine cancer	6.23e-05	0.00103	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—uterine cancer	6.21e-05	0.00102	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—uterine cancer	6.17e-05	0.00102	CcSEcCtD
Metformin—Flushing—Doxorubicin—uterine cancer	6.17e-05	0.00102	CcSEcCtD
Metformin—Flatulence—Epirubicin—uterine cancer	6.16e-05	0.00102	CcSEcCtD
Metformin—ND1—lymph node—uterine cancer	6.14e-05	0.000593	CbGeAlD
Metformin—Dysgeusia—Epirubicin—uterine cancer	6.12e-05	0.00101	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—uterine cancer	6.03e-05	0.000995	CcSEcCtD
Metformin—Dizziness—Etoposide—uterine cancer	6.02e-05	0.000993	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—uterine cancer	6.01e-05	0.000992	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—uterine cancer	6e-05	0.00099	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—uterine cancer	5.99e-05	0.000988	CcSEcCtD
Metformin—Chills—Doxorubicin—uterine cancer	5.96e-05	0.000984	CcSEcCtD
Metformin—Vision blurred—Epirubicin—uterine cancer	5.89e-05	0.000972	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—uterine cancer	5.8e-05	0.000957	CcSEcCtD
Metformin—Vomiting—Etoposide—uterine cancer	5.79e-05	0.000955	CcSEcCtD
Metformin—Erythema—Doxorubicin—uterine cancer	5.79e-05	0.000954	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—uterine cancer	5.79e-05	0.000954	CcSEcCtD
Metformin—Rash—Etoposide—uterine cancer	5.74e-05	0.000947	CcSEcCtD
Metformin—Dermatitis—Etoposide—uterine cancer	5.74e-05	0.000946	CcSEcCtD
Metformin—Headache—Etoposide—uterine cancer	5.7e-05	0.000941	CcSEcCtD
Metformin—Flatulence—Doxorubicin—uterine cancer	5.7e-05	0.000941	CcSEcCtD
Metformin—SLC22A3—female reproductive system—uterine cancer	5.68e-05	0.000549	CbGeAlD
Metformin—Dysgeusia—Doxorubicin—uterine cancer	5.67e-05	0.000935	CcSEcCtD
Metformin—Malaise—Epirubicin—uterine cancer	5.64e-05	0.00093	CcSEcCtD
Metformin—Syncope—Epirubicin—uterine cancer	5.61e-05	0.000925	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—uterine cancer	5.56e-05	0.000918	CcSEcCtD
Metformin—Palpitations—Epirubicin—uterine cancer	5.53e-05	0.000912	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—uterine cancer	5.5e-05	0.000907	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—uterine cancer	5.45e-05	0.0009	CcSEcCtD
Metformin—Nausea—Etoposide—uterine cancer	5.41e-05	0.000892	CcSEcCtD
Metformin—Hypertension—Epirubicin—uterine cancer	5.4e-05	0.000891	CcSEcCtD
Metformin—SLC22A1—vagina—uterine cancer	5.38e-05	0.00052	CbGeAlD
Metformin—Ill-defined disorder—Doxorubicin—uterine cancer	5.37e-05	0.000886	CcSEcCtD
Metformin—Chest pain—Epirubicin—uterine cancer	5.32e-05	0.000878	CcSEcCtD
Metformin—Myalgia—Epirubicin—uterine cancer	5.32e-05	0.000878	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	5.29e-05	0.000872	CcSEcCtD
Metformin—Discomfort—Epirubicin—uterine cancer	5.26e-05	0.000868	CcSEcCtD
Metformin—Malaise—Doxorubicin—uterine cancer	5.22e-05	0.000861	CcSEcCtD
Metformin—Syncope—Doxorubicin—uterine cancer	5.19e-05	0.000856	CcSEcCtD
Metformin—SLC22A3—female gonad—uterine cancer	5.17e-05	0.0005	CbGeAlD
Metformin—SLC22A3—vagina—uterine cancer	5.14e-05	0.000497	CbGeAlD
Metformin—Palpitations—Doxorubicin—uterine cancer	5.11e-05	0.000843	CcSEcCtD
Metformin—Oedema—Epirubicin—uterine cancer	5.1e-05	0.000842	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—uterine cancer	5.09e-05	0.000839	CcSEcCtD
Metformin—Infection—Epirubicin—uterine cancer	5.07e-05	0.000836	CcSEcCtD
Metformin—Shock—Epirubicin—uterine cancer	5.02e-05	0.000828	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—uterine cancer	5.01e-05	0.000826	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—uterine cancer	5e-05	0.000824	CcSEcCtD
Metformin—Hypertension—Doxorubicin—uterine cancer	5e-05	0.000824	CcSEcCtD
Metformin—Skin disorder—Epirubicin—uterine cancer	4.96e-05	0.000818	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—uterine cancer	4.93e-05	0.000814	CcSEcCtD
Metformin—Chest pain—Doxorubicin—uterine cancer	4.93e-05	0.000813	CcSEcCtD
Metformin—Myalgia—Doxorubicin—uterine cancer	4.93e-05	0.000813	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	4.89e-05	0.000807	CcSEcCtD
Metformin—Discomfort—Doxorubicin—uterine cancer	4.87e-05	0.000803	CcSEcCtD
Metformin—Anorexia—Epirubicin—uterine cancer	4.87e-05	0.000803	CcSEcCtD
Metformin—Hypotension—Epirubicin—uterine cancer	4.77e-05	0.000787	CcSEcCtD
Metformin—Oedema—Doxorubicin—uterine cancer	4.72e-05	0.000779	CcSEcCtD
Metformin—Infection—Doxorubicin—uterine cancer	4.69e-05	0.000774	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—uterine cancer	4.65e-05	0.000767	CcSEcCtD
Metformin—Shock—Doxorubicin—uterine cancer	4.65e-05	0.000766	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—uterine cancer	4.63e-05	0.000764	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—uterine cancer	4.62e-05	0.000763	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—uterine cancer	4.59e-05	0.000757	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—uterine cancer	4.58e-05	0.000756	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—uterine cancer	4.57e-05	0.000753	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—uterine cancer	4.55e-05	0.000751	CcSEcCtD
Metformin—Somnolence—Epirubicin—uterine cancer	4.54e-05	0.000748	CcSEcCtD
Metformin—Anorexia—Doxorubicin—uterine cancer	4.5e-05	0.000743	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—uterine cancer	4.49e-05	0.000741	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—uterine cancer	4.44e-05	0.000732	CcSEcCtD
Metformin—Hypotension—Doxorubicin—uterine cancer	4.41e-05	0.000728	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—uterine cancer	4.41e-05	0.000727	CcSEcCtD
Metformin—Fatigue—Epirubicin—uterine cancer	4.4e-05	0.000726	CcSEcCtD
Metformin—Constipation—Epirubicin—uterine cancer	4.36e-05	0.00072	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	4.3e-05	0.00071	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—uterine cancer	4.24e-05	0.000699	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—uterine cancer	4.21e-05	0.000694	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—uterine cancer	4.21e-05	0.000694	CcSEcCtD
Metformin—Somnolence—Doxorubicin—uterine cancer	4.2e-05	0.000693	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—uterine cancer	4.17e-05	0.000688	CcSEcCtD
Metformin—SLC47A1—lymph node—uterine cancer	4.17e-05	0.000403	CbGeAlD
Metformin—Dyspepsia—Doxorubicin—uterine cancer	4.16e-05	0.000686	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—uterine cancer	4.11e-05	0.000677	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.08e-05	0.000673	CcSEcCtD
Metformin—Fatigue—Doxorubicin—uterine cancer	4.07e-05	0.000672	CcSEcCtD
Metformin—Urticaria—Epirubicin—uterine cancer	4.05e-05	0.000669	CcSEcCtD
Metformin—Constipation—Doxorubicin—uterine cancer	4.04e-05	0.000666	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—uterine cancer	4.03e-05	0.000666	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—uterine cancer	3.89e-05	0.000642	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—uterine cancer	3.86e-05	0.000637	CcSEcCtD
Metformin—Urticaria—Doxorubicin—uterine cancer	3.75e-05	0.000619	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—uterine cancer	3.73e-05	0.000616	CcSEcCtD
Metformin—Asthenia—Epirubicin—uterine cancer	3.66e-05	0.000604	CcSEcCtD
Metformin—Pruritus—Epirubicin—uterine cancer	3.61e-05	0.000596	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—uterine cancer	3.49e-05	0.000576	CcSEcCtD
Metformin—Asthenia—Doxorubicin—uterine cancer	3.39e-05	0.000559	CcSEcCtD
Metformin—Dizziness—Epirubicin—uterine cancer	3.38e-05	0.000557	CcSEcCtD
Metformin—Pruritus—Doxorubicin—uterine cancer	3.34e-05	0.000551	CcSEcCtD
Metformin—SLC22A3—lymph node—uterine cancer	3.32e-05	0.000321	CbGeAlD
Metformin—Vomiting—Epirubicin—uterine cancer	3.25e-05	0.000535	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—uterine cancer	3.23e-05	0.000533	CcSEcCtD
Metformin—Rash—Epirubicin—uterine cancer	3.22e-05	0.000531	CcSEcCtD
Metformin—Dermatitis—Epirubicin—uterine cancer	3.22e-05	0.00053	CcSEcCtD
Metformin—Headache—Epirubicin—uterine cancer	3.2e-05	0.000527	CcSEcCtD
Metformin—Dizziness—Doxorubicin—uterine cancer	3.12e-05	0.000515	CcSEcCtD
Metformin—Nausea—Epirubicin—uterine cancer	3.03e-05	0.0005	CcSEcCtD
Metformin—Vomiting—Doxorubicin—uterine cancer	3e-05	0.000495	CcSEcCtD
Metformin—Rash—Doxorubicin—uterine cancer	2.98e-05	0.000491	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—uterine cancer	2.97e-05	0.000491	CcSEcCtD
Metformin—Headache—Doxorubicin—uterine cancer	2.96e-05	0.000488	CcSEcCtD
Metformin—Nausea—Doxorubicin—uterine cancer	2.81e-05	0.000463	CcSEcCtD
Metformin—NDUFA12—Metabolism—PTEN—uterine cancer	8.72e-06	9.15e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PTEN—uterine cancer	8.72e-06	9.15e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SRD5A2—uterine cancer	8.7e-06	9.13e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NDUFB11—uterine cancer	8.7e-06	9.13e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FBXW7—uterine cancer	8.36e-06	8.78e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—EP300—uterine cancer	8.32e-06	8.73e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—EP300—uterine cancer	8.32e-06	8.73e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—EP300—uterine cancer	8.32e-06	8.73e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—EP300—uterine cancer	8.32e-06	8.73e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTEN—uterine cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NDUFB11—uterine cancer	8.1e-06	8.51e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SRD5A2—uterine cancer	8.1e-06	8.51e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—POLD1—uterine cancer	7.87e-06	8.26e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—EP300—uterine cancer	7.73e-06	8.12e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKR1C1—uterine cancer	7.36e-06	7.72e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STK11—uterine cancer	7.31e-06	7.67e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTEN—uterine cancer	7.23e-06	7.59e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—MTHFR—uterine cancer	7.12e-06	7.47e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—EP300—uterine cancer	6.89e-06	7.23e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SOCS3—uterine cancer	6.84e-06	7.18e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PIK3CA—uterine cancer	6.73e-06	7.06e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—RRM2—uterine cancer	6.56e-06	6.88e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN2B—uterine cancer	6.55e-06	6.88e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—DCN—uterine cancer	6.37e-06	6.68e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF1R—uterine cancer	6.36e-06	6.68e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKR1B1—uterine cancer	6.29e-06	6.6e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—STAR—uterine cancer	6.29e-06	6.6e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PIK3CA—uterine cancer	6.15e-06	6.46e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PIK3CA—uterine cancer	6.15e-06	6.46e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PIK3CA—uterine cancer	6.15e-06	6.46e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PIK3CA—uterine cancer	6.15e-06	6.46e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTEN—uterine cancer	6.14e-06	6.45e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTEN—uterine cancer	6.14e-06	6.45e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTEN—uterine cancer	6.14e-06	6.45e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP11A1—uterine cancer	6e-06	6.3e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SMAD3—uterine cancer	5.98e-06	6.28e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—STAR—uterine cancer	5.86e-06	6.15e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—EP300—uterine cancer	5.86e-06	6.15e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKR1B1—uterine cancer	5.86e-06	6.15e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—EP300—uterine cancer	5.86e-06	6.15e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—EP300—uterine cancer	5.86e-06	6.15e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTEN—uterine cancer	5.78e-06	6.06e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PIK3CA—uterine cancer	5.72e-06	6e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGFR2—uterine cancer	5.71e-06	5.99e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKR1C3—uterine cancer	5.66e-06	5.95e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—EP300—uterine cancer	5.51e-06	5.78e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—uterine cancer	5.49e-06	5.77e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—uterine cancer	5.1e-06	5.35e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—uterine cancer	5.03e-06	5.28e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—uterine cancer	5.03e-06	5.28e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—uterine cancer	5.03e-06	5.28e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—uterine cancer	5.03e-06	5.28e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—POLD1—uterine cancer	4.93e-06	5.18e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ESR1—uterine cancer	4.88e-06	5.12e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—uterine cancer	4.67e-06	4.9e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKR1C1—uterine cancer	4.61e-06	4.84e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—POLD1—uterine cancer	4.6e-06	4.83e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—STK11—uterine cancer	4.41e-06	4.63e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP19A1—uterine cancer	4.41e-06	4.63e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—uterine cancer	4.33e-06	4.55e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—uterine cancer	4.33e-06	4.55e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—uterine cancer	4.33e-06	4.55e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKR1C1—uterine cancer	4.3e-06	4.51e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL2—uterine cancer	4.3e-06	4.51e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—uterine cancer	4.16e-06	4.37e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—RRM2—uterine cancer	4.11e-06	4.32e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—uterine cancer	4.08e-06	4.28e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—DCN—uterine cancer	3.99e-06	4.19e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—uterine cancer	3.96e-06	4.16e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	3.91e-06	4.11e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—RRM2—uterine cancer	3.83e-06	4.02e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—EP300—uterine cancer	3.78e-06	3.96e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP11A1—uterine cancer	3.76e-06	3.95e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—DCN—uterine cancer	3.72e-06	3.91e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	3.65e-06	3.83e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB2—uterine cancer	3.58e-06	3.76e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKR1C3—uterine cancer	3.55e-06	3.73e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—uterine cancer	3.54e-06	3.72e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—uterine cancer	3.54e-06	3.72e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—uterine cancer	3.54e-06	3.72e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP11A1—uterine cancer	3.51e-06	3.68e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—uterine cancer	3.4e-06	3.57e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—uterine cancer	3.33e-06	3.49e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1B—uterine cancer	3.32e-06	3.48e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—MTHFR—uterine cancer	3.32e-06	3.48e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKR1C3—uterine cancer	3.31e-06	3.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—uterine cancer	3.13e-06	3.29e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—uterine cancer	3.06e-06	3.21e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—uterine cancer	3e-06	3.15e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EP300—uterine cancer	2.91e-06	3.06e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—uterine cancer	2.79e-06	2.93e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—uterine cancer	2.79e-06	2.93e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—STK11—uterine cancer	2.77e-06	2.91e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP19A1—uterine cancer	2.77e-06	2.91e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—uterine cancer	2.76e-06	2.9e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRAS—uterine cancer	2.73e-06	2.86e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—STK11—uterine cancer	2.58e-06	2.71e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP19A1—uterine cancer	2.58e-06	2.71e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—uterine cancer	2.35e-06	2.46e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—uterine cancer	2.28e-06	2.4e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—uterine cancer	2.16e-06	2.26e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—uterine cancer	2.09e-06	2.19e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTHFR—uterine cancer	2.08e-06	2.18e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—uterine cancer	1.99e-06	2.09e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTHFR—uterine cancer	1.94e-06	2.03e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—uterine cancer	1.84e-06	1.94e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—uterine cancer	1.76e-06	1.85e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—EP300—uterine cancer	1.76e-06	1.85e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—uterine cancer	1.3e-06	1.37e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—uterine cancer	1.16e-06	1.21e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—EP300—uterine cancer	1.1e-06	1.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—uterine cancer	1.08e-06	1.13e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—uterine cancer	1.06e-06	1.12e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—EP300—uterine cancer	1.03e-06	1.08e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—uterine cancer	8.16e-07	8.57e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—uterine cancer	7.61e-07	7.99e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—uterine cancer	6.67e-07	7e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—uterine cancer	6.21e-07	6.52e-06	CbGpPWpGaD
